Transurethral resection for urethral recurrence after neobladder reconstruction in patients with bladder cancer
10.3760/cma.j.issn.1000-6702.2010.12.019
- VernacularTitle:TUR术治疗原位新膀胱术后再发尿道癌
- Author:
Shaoliang WANG
;
Youming XU
;
Shulong WANG
;
Jianhua YU
- Publication Type:Journal Article
- Keywords:
Bladder neoplasms;
Carcinoma;
Urethral neoplasms;
Recurrence
- From:
Chinese Journal of Urology
2010;31(12):844-846
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the surgical treatment of urethral recurrence after neobladder reconstruction in patients with bladder cancer. Methods In 89 consecutive patients with radical cystectomy, 5 patients (5.6%) presented with a noninvasive urethral recurrence at a median of 18 months (range 9 to 32 months). All 5 patients were treated by transurethral resection and intraurethral instillation with hydroxycamptothecin used as initial therapy. Mean follow-up was 37 months (24 - 52 months). Results All the 5 patients survived after the treatment. There was no one showed recurrence or distant metastasis. All the 5 cases achieved continence. Conclusion Urethral preservation at initial therapy for incipient noninvasive urethral recurrence would be a good choice and could maintain the quality of life.
